Bladder cancer risk from occupational and environmental exposures (Q37990118)

26 August 2017

title

Bladder cancer risk from occupational and environmental exposures (English)

1 reference

26 August 2017

1 reference

Kyle J Kiriluk

1

1 reference

26 August 2017

Sandip M Prasad

2

1 reference

26 August 2017

Amit R Patel

3

1 reference

26 August 2017

Gary D Steinberg

4

1 reference

26 August 2017

Norm D Smith

5

1 reference

26 August 2017

publication date

1 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

30

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

199-211

1 reference

Ludwig Rehn (1849-1930)--pioneering findings on the aetiology of bladder tumours

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Familial Transitional Cell Carcinoma of the Bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Familial bladder cancer in an oncology clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Familial Transitional Cell Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Risk of transitional-cell carcinoma of the bladder in first- and second-generation immigrants to Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Familial Transitional Cell Carcinoma Among the Population of Iceland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Segregation analysis of urothelial cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Environmental factors and genetic susceptibility promote urinary bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Risk of bladder cancer by source and type of tobacco exposure: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Papillary carcinoma of the bladder in mice, obtained after peroral administration of tobacco tar

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

THE RELATIONSHIP OF BLADDER CANCER TO SMOKING.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Tobacco, occupation and non-transitional-cell carcinoma of the bladder: an international case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Association of secondhand smoke exposures with DNA methylation in bladder carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Cigar and pipe smoking and cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Cigar, pipe, and cigarette smoking and bladder cancer risk in European men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Secondhand smoking, 4-aminobiphenyl, and bladder cancer: two meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Biomonitoring of smoke constituents: exposure to 4-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in nonsmokers and smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Cigarette smoking and bladder cancer: a new twist in an old saga?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Environmental factors promoting bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Excretion of mutagens, nicotine and its metabolites in urine of cigarette smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Increased bladder cancer risk among workers exposed to o-toluidine and aniline: a reanalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Bladder cancer mortality of workers exposed to aromatic amines: a 58-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

A descriptive study of occupation and bladder cancer in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Bladder cancer among French farmers: does exposure to pesticides in vineyards play a part?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Cancer and birth defects near the Drake Superfund site, Pennsylvania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

The Drake Health Registry Study: cause-specific mortality experience of workers potentially exposed to beta-naphthylamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

A re-examination of the cause of excess bladder cancers in chemical plant workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

The first reported cases of human bladder tumors due to a new carcinogen-xenylamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Carcinogenicity of some aromatic amines, organic dyes, and related exposures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Neoplastic transformation and DNA-binding of 4,4'-methylenebis(2-chloroaniline) in SV40-immortalized human uroepithelial cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Bladder cancer among hairdressers: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Risk of cancer among hairdressers and related workers: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Hair dye use and risk of bladder cancer in the New England bladder cancer study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

The debate on carcinogenicity of permanent hair dyes: new insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

The incidence of bladder cancer in the black foot disease endemic area in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Arsenic ingestion and internal cancers: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Bladder cancer mortality associated with arsenic in drinking water in Argentina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Case-control study of bladder cancer and drinking water arsenic in the western United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Incidence of Transitional Cell Carcinoma and Arsenic in Drinking Water: A Follow-up Study of 8,102 Residents in an Arseniasis-endemic Area in Northeastern Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Arsenic toxicity, mutagenesis, and carcinogenesis--a health risk assessment and management approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Occupational Exposure to Polycyclic Aromatic Hydrocarbons and the Risk of Bladder Cancer: A French Case-Control Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Carcinogenicity of polycyclic aromatic hydrocarbons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Population densities in relation to bladder cancer mortality rates in America from 1950 to 1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Critical review of the epidemiological literature on occupational exposure to perchloroethylene and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Chronic inflammation and bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

A wake up call for urinary schistosomiasis: reconciling research effort with public health importance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Incidence of squamous cell carcinoma in patients with long-term catheter drainage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Screening cystoscopy and biopsy in patients with neuropathic bladder and chronic suprapubic indwelling catheters: is it valid?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Human papillomavirus oncoproteins: pathways to transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Human papillomavirus is detected in transitional cell carcinoma arising in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Human Papillomavirus Infection and Bladder Cancer Risk: A Meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Meta-analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Bladder cancer in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Cancer incidence before and after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Glucocorticoid therapy and risk of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Cyclophosphamide and the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Carcinoma of the Urinary Bladder after Treatment with Cyclophosphamide for Non-Hodgkin's Lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Cyclophosphamide cystitis—Identification of acrolein as the causative agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Uroepithelial tumors of the renal pelvis associated with abuse of phenacetin-containing analgesics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Carcinogenicity of phenacetin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Phenacetin abuse related to bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Heavy phenacetin use and bladder cancer in women aged 20 to 49 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Role of CYP1A2 in the toxicity of long-term phenacetin feeding in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Urothelial lesions in Chinese-herb nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Carcinogenicity of saccharin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Long-term Feeding of Sodium Saccharin to Nonhuman Primates: Implications for Urinary Tract Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Calcium phosphate-containing precipitate and the carcinogenicity of sodium salts in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Artificial sweeteners--do they bear a carcinogenic risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Nitrate in drinking water and risk of death from bladder cancer: an ecological case-control study in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Nitrate in public water supplies and risk of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Nitrate intake does not influence bladder cancer risk: the Netherlands cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Meat and components of meat and the risk of bladder cancer in the NIH‐AARP Diet and Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Disinfection byproducts and bladder cancer: a pooled analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Water disinfection by-products and bladder cancer: is there a European specificity? A pooled and meta-analysis of European case-control studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Do sunlight and vitamin D reduce the likelihood of colon cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Serum vitamin D and risk of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Ultraviolet B irradiance and incidence rates of bladder cancer in 174 countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Florida bladder cancer trends 1981 to 2004: minimal progress in decreasing advanced disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Sex and racial differences in bladder cancer presentation and mortality in the US

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Bladder cancer clusters in Florida: identifying populations at risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Latency analysis in epidemiologic studies of occupational exposures: application to the Colorado Plateau uranium miners cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.10.010

Arsenic: toxicity, oxidative stress and human disease

7 January 2021

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/JAT.1649

10.1016/J.UROLONC.2011.10.010

8 August 2024

Identifiers

DOI

1 reference

26 August 2017

1 reference